Candriam SCA’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Candriam SCA’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-175,000	Closed	-$2.15M	–	950
2022 Q4	$2.15M	Buy	175,000 +130,000	+289%	+$3.1M	0.01%	566
2022 Q3	$1.48M	Buy	+45,000	New	+$1.27M	0.01%	647

Candriam SCA's CINC Position: Q1 2023 in Review

Candriam SCA sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 175,000 shares — an estimated $2.15M sold.

Candriam SCA first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $2.15M in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Candriam SCA reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Candriam SCA sold 175,000 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $2.15M.
Candriam SCA first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Candriam SCA's CinCor Pharma, Inc. Common Stock position peaked at $2.15M in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.